Armodafinil Tablets: Uses, Benefits and Important Information

Meta Description: Get to know more about armodafinil tablets, its approved indications for excessive sleepiness, strength of medication, and relevant facts about therapy. Introduction Armodafinil tablets refer to prescription drugs with armodafinil, a wakefulness-promoting agent as active ingredient. In Australia, the approval of armodafinil is for improvement of wakefulness in patients suffering from excessive sleepiness because of certain sleep conditions. According to the Australian TGA, there are three strengths of armodafinil tablets: 50 mg, 150 mg and 250 mg. Armodafinil belongs to the same class of medications as modafinil, and it is prescribed only in cases where excessive sleepiness occurs in relation to an underlying condition of sleep disorders. What Are Armodafinil Tablets? Armodafinil is the R-enantiomer of modafinil and belongs to a group of medicines that promote wakefulness. The precise mechanism by which armodafinil produces wakefulness is not completely understood, although it has pharmacological effects involving the dopamine transporter. Australian-approved Nuvigil tablets are available in 50 mg, 150 mg and 250 mg strengths. The appropriate strength depends on the condition being treated and the individual's medical circumstances. What Are Armodafinil Tablets Used For? Armodafinil tablets have specific approved uses in Australia. They are used to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy. They can also be used for excessive sleepiness associated with moderate to severe chronic shift work sleep disorder, when non-drug measures are unsuccessful or inappropriate. Another approved use is as an adjunct to continuous positive airway pressure (CPAP) in obstructive sleep apnoea/hypopnoea syndrome to improve wakefulness. These indications mean that armodafinil should be used for diagnosed sleep-related conditions rather than ordinary tiredness. How Are the Tablets Selected? The tablet strength is not something a person should select independently. According to Australian product information, treatment should follow an evaluation of the excessive sleepiness and the underlying disorder. Treatment is intended to be initiated and supervised by physicians experienced in managing sleep disorders. For example, the Australian clinical information describes different recommended dosing approaches for different sleep disorders. This is one reason medical assessment is important before starting treatment. Armodafinil and Daytime Wakefulness One of the main purposes of armodafinil treatment is to help patients remain awake and alert during appropriate waking periods. For someone with a diagnosed sleep disorder, excessive daytime sleepiness can interfere with work, study, driving and everyday activities. However, feeling tired does not automatically mean that armodafinil is appropriate. Poor sleep, an untreated sleep disorder or other medical factors may contribute to daytime sleepiness. A proper assessment can help identify the underlying reason. Why Medical Guidance Matters Armodafinil is a prescription medicine in Australia. The TGA's assessment identifies Nuvigil as a prescription medicine and specifies that patients should have a complete evaluation of their excessive sleepiness before treatment. A doctor can assess symptoms, review existing treatments and determine whether armodafinil is suitable. This is particularly important for people who have not received a diagnosis for their excessive sleepiness. It is also important not to confuse armodafinil with a general cognitive-enhancement product. Using prescription wakefulness medicines without an appropriate medical indication is not the same as treating a diagnosed sleep disorder. Armodafinil Tablets in Australia The TGA's Australian Register of Therapeutic Goods includes Nuvigil armodafinil tablets in 50 mg, 150 mg and 250 mg strengths. Because armodafinil is prescription-only, Australians should obtain it through appropriate medical and pharmacy channels. The TGA also warns consumers about purchasing prescription medicines from overseas online vendors without the required prescription. Conclusion Armodafinil tablets are wakefulness-promoting prescription medicines with specific approved uses in Australia. They can help improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy, chronic shift work sleep disorder and, alongside CPAP, obstructive sleep apnoea/hypopnoea syndrome. The correct strength and treatment plan depend on the individual's diagnosed condition and medical assessment. Anyone experiencing persistent excessive daytime sleepiness should speak with a qualified doctor rather than using armodafinil independently. https://www.armodafinil.com.au/product/artvigil-50-mg